, Tracking Stock Market Picks
Enter Symbol:
Rating: THLDD
Buy $15

THRESHOLD PHARMACEUT (NASDAQ: THLD) rated to Buy with price target $15 by Brean Capital

Tuesday,  Jul 8, 2014  12:00 AM ET by Kristen Bailey

Brean Capital rated THRESHOLD
PHARMACEUT (NASDAQ: THLD) to Buy with price target $15.

Threshold is focused on the discovery, development, and commercialization of small molecule therapeutics based on `Metabolic Targeting.` This approach targets abnormal glucose metabolism - a fundamental property of most solid tumors and other diseases. The company's initial focus is the treatment of cancer and benign prostatic hyperplasia, a disease characterized by overgrowth of the prostate.

Brean Capital

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy